Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Statins
100%
Beta-blockers
100%
Long-term Mortality
100%
Vascular Surgery
100%
Hazard Ratio
33%
Number-needed-to-treat
33%
All Levels
22%
Postoperative Outcomes
22%
Risk Level
22%
Revised Cardiac Risk Index
22%
Retrospective Cohort Study
11%
Clinical High Risk
11%
Drug Use
11%
Veterans Affairs Medical Center
11%
Survival Analysis
11%
Day of Surgery
11%
Combination Studies
11%
Combination Use
11%
Propensity Score Stratification
11%
Propensity Score Methods
11%
Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Vascular Surgery
100%
Statin
100%
Hazard Ratio
33%
Numbers Needed to Treat
33%
Revised Cardiac Risk Index
22%
Veterans Affairs
11%
Retrospective Cohort Study
11%
Survival Analysis
11%
Day of Surgery
11%
Median Follow Up
11%
Nursing and Health Professions
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Beta Adrenergic Receptor Blocking Agent
100%
Vascular Surgery
100%
Hazard Ratio
33%
Numbers Needed to Treat
33%
Cohort Analysis
11%
Statin (Protein)
11%
Survival Analysis
11%
Propensity Score
11%
Patient Benefit
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Beta Adrenergic Receptor Blocking Agent
100%
Number Needed to Treat
33%
Statin (Protein)
11%
Cohort Study
11%